Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris
- PMID: 1534342
- DOI: 10.1111/1523-1747.ep12460324
Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris
Abstract
The factors that initiate the inflammatory response in acne are not known. The presence of pro-inflammatory cytokines in acne comedones was therefore investigated. One hundred eight open comedones were collected from 18 untreated acne patients (10 male, 8 female). Each comedone was homogenized and centrifuged, and the supernatant was analyzed for bioactive and immunochemically detectable IL-1 alpha, IL-1 beta, and TNF alpha. Viable counts of propionibacteria, staphylococci, and Malassezia spp. were determined in the comedone pellet. Bioactive IL-1 alpha-like material was demonstrated in 76% of open comedones (range of 23-4765 pg IL-1 alpha-like bioactivity/mg of comedone material). In 58% of comedones, levels exceeded 100 pg/mg. There was no correlation between IL-1 alpha-like bioactivity and IL-1 alpha determined immunochemically. Bioactive IL-1 beta was not detected in any comedones. Twenty-four percent contained low levels of immunochemical IL-1 beta (range 12-103 pg IL-1 beta/mg comedone material). Bioactive TNF alpha was detected in three comedones with a further five comedones containing immunochemical TNF alpha (range of 61-820 pg TNF alpha/mg comedone material). The majority of open comedones (97%) contained microorganisms. There was, however, no significant correlation (Spearman's rank) between levels of any cytokine, in particular IL-1 alpha-like bioactivity, and numbers of microorganisms. Thus, bioactive IL-1 alpha-like material in the majority of open comedones may be concerned in the initiation of inflammation in acne following spongiosis or rupture of the pilosebaceous follicle wall.
Similar articles
-
Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines.J Invest Dermatol. 1993 Jul;101(1):86-91. doi: 10.1111/1523-1747.ep12360123. J Invest Dermatol. 1993. PMID: 8331300
-
Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris.Br J Dermatol. 1994 Nov;131(5):649-54. doi: 10.1111/j.1365-2133.1994.tb04976.x. Br J Dermatol. 1994. PMID: 7999595
-
Skin surface and open comedone pH in acne patients.Acta Derm Venereol. 1983;63(2):155-8. Acta Derm Venereol. 1983. PMID: 6189333
-
Strategic Targets in Acne: The Comedone Switch in Question.Dermatology. 2015;231(2):105-11. doi: 10.1159/000382031. Epub 2015 Jun 23. Dermatology. 2015. PMID: 26113292 Review.
-
Comedone formation: etiology, clinical presentation, and treatment.Clin Dermatol. 2004 Sep-Oct;22(5):367-74. doi: 10.1016/j.clindermatol.2004.03.011. Clin Dermatol. 2004. PMID: 15556720 Review.
Cited by
-
Cutaneous lesions of the nose.Head Face Med. 2010 Jun 4;6:7. doi: 10.1186/1746-160X-6-7. Head Face Med. 2010. PMID: 20525327 Free PMC article. Review.
-
Role of FGFR2-signaling in the pathogenesis of acne.Dermatoendocrinol. 2009 May;1(3):141-56. doi: 10.4161/derm.1.3.8474. Dermatoendocrinol. 2009. PMID: 20436882 Free PMC article.
-
Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne.Drug Des Devel Ther. 2023 Jan 11;17:39-53. doi: 10.2147/DDDT.S385208. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36660250 Free PMC article.
-
IL-17: a key player in the P. acnes inflammatory cascade?J Invest Dermatol. 2014 Feb;134(2):307-310. doi: 10.1038/jid.2013.400. J Invest Dermatol. 2014. PMID: 24424453
-
Propionibacterium acnes and Acne Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies.Microorganisms. 2019 May 13;7(5):128. doi: 10.3390/microorganisms7050128. Microorganisms. 2019. PMID: 31086023 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous